Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 7c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Wendy's U.S. president to resign, company to create COO role